This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cross Country (CCRN) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Cross Country (CCRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Earnings Estimates Rising for Cross Country (CCRN): Will It Gain?
by Zacks Equity Research
Cross Country (CCRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks.com featured highlights include: Ford, Bed Bath & Beyond, Bunge, Cross Country Healthcare and Bloomin' Brands
by Zacks Equity Research
Zacks.com featured highlights include: Ford, Bed Bath & Beyond, Bunge, Cross Country Healthcare and Bloomin' Brands
Rating Upgrade by Brokers Puts These 5 Stocks in Focus
by Maharathi Basu
Investors pursue broker advice for shaping a portfolio of lucrative stocks. Let's check out a few broker favorites like Ford (F), Bed Bath & Beyond (BBBY), Bunge (BG), Cross Country Healthcare (CCRN) and Bloomin' Brands (BLMN).
Cross Country Healthcare (CCRN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 500.00% and 11.40%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Cross Country Healthcare (CCRN) Ahead of Earnings?
by Zacks Equity Research
Cross Country Healthcare (CCRN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Cross Country Healthcare's (CCRN) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Cross Country Healthcare, Inc. (CCRN).
Lumen (LUMN) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Lumen's (LUMN) top-line growth in third-quarter 2020 is likely to have been hurt by coronavirus-induced adversities.
Cross Country Healthcare (CCRN) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Cross Country (CCRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BGSF vs. CCRN: Which Stock Is the Better Value Option?
by Zacks Equity Research
BGSF vs. CCRN: Which Stock Is the Better Value Option?
5 Stocks to Gain as Jobless Rate Falls for Fifth Straight Month
by Tirthankar Chakraborty
Since May, nearly 11.4 million jobs have been recovered. Lest we forget, the U.S. economy lost a whopping 23 million jobs at the beginning of the coronavirus pandemic.
Is Cross Country Healthcare (CCRN) Stock a Good Value Pick?
by Zacks Equity Research
Let's see if Cross Country Healthcare, Inc. (CCRN) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Earnings Preview: Cross Country Healthcare (CCRN) Q2 Earnings Expected to Decline
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cross Country Healthcare (CCRN) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 50.00% and 0.16%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cross Country Healthcare (CCRN) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 16.67% and 3.15%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Cross Country Healthcare, KB Home, Hilton Grand Vacations, Tenet Healthcare and G-III Apparel
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cross Country Healthcare, KB Home, Hilton Grand Vacations, Tenet Healthcare and G-III Apparel
U.S. Labor Market on a Solid Footing: Top 5 Winners
by Tirthankar Chakraborty
The U.S. economy added 225,000 jobs in January as workers rejoin the labor force and wages rise slightly. Here's a rundown on the strong job growth's big winners --
Which Business Services Stocks Could be the Copart of 2020?
by Shuvra Shankar Dey
The business services sector is a major beneficiary of the broader economy, which is expected to get stronger in 2020.
Cross Country Healthcare Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Cross Country Healthcare has been struggling lately, but the selling pressure may be coming to an end soon.
The Zacks Analyst Blog Highlights: Cross Country Healthcare, Genesis Healthcare, Chuy's, Consulting and Huron Consulting
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cross Country Healthcare, Genesis Healthcare, Chuy's, Consulting and Huron Consulting
5 Top Stocks to Buy on Blockbuster Jobs Data
by Zacks Equity Research
U.S. non-farm payroll data for November shows that job creation hasn't slowed but has shown signs of reacceleration. Here are five stocks from the best-performing sectors.
Why ServiceMaster (SERV) Could Be Positioned for a Slump
by Zacks Equity Research
ServiceMaster (SERV) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
What Makes Cross Country Healthcare (CCRN) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Cross Country Healthcare (CCRN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Stock Market News for Nov 6, 2019
by Zacks Equity Research
Wall Street made nominal progress on Nov 5, given the record highs major indexes reached on Monday.